BB Biotech AG (BION.SW)
- Previous Close
41.60 - Open
41.50 - Bid --
- Ask --
- Day's Range
41.20 - 41.60 - 52 Week Range
35.35 - 49.80 - Volume
57,178 - Avg. Volume
67,645 - Market Cap (intraday)
2.273B - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
-- - EPS (TTM)
-3.77 - Earnings Date Apr 26, 2024
- Forward Dividend & Yield 2.00 (4.81%)
- Ex-Dividend Date Mar 25, 2024
- 1y Target Est
--
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
www.bbbiotech.ch/en/bb-biotech/Recent News: BION.SW
Performance Overview: BION.SW
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BION.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BION.SW
Valuation Measures
Market Cap
2.28B
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.98
Enterprise Value/Revenue
0.53
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-0.76%
Return on Equity (ttm)
-8.25%
Revenue (ttm)
35k
Net Income Avi to Common (ttm)
-206.61M
Diluted EPS (ttm)
-3.77
Balance Sheet and Cash Flow
Total Cash (mrq)
2.64B
Total Debt/Equity (mrq)
13.12%
Levered Free Cash Flow (ttm)
-22.32M
Company Insights: BION.SW
BION.SW does not have Company Insights